Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects
NCT02882425
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
Selexipag for intravenous use
DRUG:
Selexipag for oral use
Sponsor
Actelion